Immune responses to Neisseria gonorrhoeae and implications for vaccine development

Thomas Belcher; Christine S. Rollier; Christina Dold; Jonathan D.C. Ross; Calman A. MacLennan

doi:10.3389/fimmu.2023.1248613

Immune responses to Neisseria gonorrhoeae and implications for vaccine development

Thomas Belcher^*
, Christine S. Rollier
, Christina Dold
, Jonathan D.C. Ross
, Calman A. MacLennan

^*Corresponding author for this work

University of Oxford
University of Surrey
University Hospitals Birmingham NHS Foundation Trust

Research output: Contribution to journal › Review article › peer-review

24 Citations (SciVal)

Original language	English
Article number	1248613
Journal	Frontiers in Immunology
Volume	14
DOIs	https://doi.org/10.3389/fimmu.2023.1248613
Publication status	Published (VoR) - 2023

Funding

Research reported in this publication is supported by CARB-X. CARB-X’s funding for this project is provided in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; under agreement number: 75A50122C00028, and by awards from Wellcome (WT224842), Germany’s Federal Ministry of Education and Research (BMBF), and the UK Global Antimicrobial Resistance Innovation Fund (GAMRIF) funded by the UK Government Department of Health and Social Care (DHSC). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of CARB-X or any of its funders. Acknowledgments

Keywords

gonococcus
gonorrhea
immunology
Neisseria
STI
vaccines

Access to Document

10.3389/fimmu.2023.1248613

Cite this

@article{b81d73c0b8a84d1bb4aa3536c8f2d430,

title = "Immune responses to Neisseria gonorrhoeae and implications for vaccine development",

keywords = "gonococcus, gonorrhea, immunology, Neisseria, STI, vaccines",

author = "Thomas Belcher and Rollier, \{Christine S.\} and Christina Dold and Ross, \{Jonathan D.C.\} and MacLennan, \{Calman A.\}",

note = "Funding Information: Research reported in this publication is supported by CARB-X. CARB-X{\textquoteright}s funding for this project is provided in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; under agreement number: 75A50122C00028, and by awards from Wellcome (WT224842), Germany{\textquoteright}s Federal Ministry of Education and Research (BMBF), and the UK Global Antimicrobial Resistance Innovation Fund (GAMRIF) funded by the UK Government Department of Health and Social Care (DHSC). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of CARB-X or any of its funders. Acknowledgments Publisher Copyright: Copyright {\textcopyright} 2023 Belcher, Rollier, Dold, Ross and MacLennan.",

year = "2023",

doi = "10.3389/fimmu.2023.1248613",

language = "English",

volume = "14",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media",

}

TY - JOUR

T1 - Immune responses to Neisseria gonorrhoeae and implications for vaccine development

AU - Belcher, Thomas

AU - Rollier, Christine S.

AU - Dold, Christina

AU - Ross, Jonathan D.C.

AU - MacLennan, Calman A.

N1 - Funding Information: Research reported in this publication is supported by CARB-X. CARB-X’s funding for this project is provided in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; under agreement number: 75A50122C00028, and by awards from Wellcome (WT224842), Germany’s Federal Ministry of Education and Research (BMBF), and the UK Global Antimicrobial Resistance Innovation Fund (GAMRIF) funded by the UK Government Department of Health and Social Care (DHSC). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of CARB-X or any of its funders. Acknowledgments Publisher Copyright: Copyright © 2023 Belcher, Rollier, Dold, Ross and MacLennan.

PY - 2023

Y1 - 2023

KW - gonococcus

KW - gonorrhea

KW - immunology

KW - Neisseria

KW - STI

KW - vaccines

UR - https://www.scopus.com/pages/publications/85169603686

UR - https://www.scopus.com/pages/publications/85169603686#tab=citedBy

U2 - 10.3389/fimmu.2023.1248613

DO - 10.3389/fimmu.2023.1248613

M3 - Review article

C2 - 37662926

AN - SCOPUS:85169603686

SN - 1664-3224

VL - 14

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1248613

ER -

Immune responses to Neisseria gonorrhoeae and implications for vaccine development

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this